Is this you? Create Your Porfile
Avatar

M.V. Gutierrez-Ardila

Pfizer

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where M.V. Gutierrez-Ardila is active.

Explore More

Publication

Featured researches published by M.V. Gutierrez-Ardila.

Value in Health | 2014

Contribution Of Health Economics & Outcomes Research Studies Of Colombia To Ispor Conferences

M.V. Gutierrez-Ardila; N. Vargas Zea

Value in Health | 2013

Cost Effectiveness Analysis Of Vaccination With 13-Valent (Pcv13) And 23-Valent (Ppsv23) Pneumococcal Vaccines For Adults In A Private Colombian Institution

J.E. Ordoñez Molina; M.V. Gutierrez-Ardila; N. Vargas Zea

Value in Health | 2013

Cost Effectiveness Analysis Of Vaccination With 13-Valent (Pcv13) And 23-Valent (Ppsv23) Pneumococcal Vaccines For Adults In Bogota, Colombia – Public Scenario

J.E. Ordoñez Molina; M.V. Gutierrez-Ardila; N. Vargas Zea

Value in Health | 2012

PIN28 Cost Effectiveness Analysis of Vaccination With 13-Valent (PCV13) and 23-Valent (PPSV23) Pneumococcal Vaccines for Adults in Colombia

S.M. Nuñez; J.F. Mould-Quevedo; M.V. Gutierrez-Ardila; C.S. Roberts; J.E. La Rotta

Value in Health | 2016

Depression and Coronary Heart Disease Risk: An Overview of Systematic Reviews

Jm Reyes; M.V. Gutierrez-Ardila; C Lopez-Cabra

Value in Health | 2016

BUDGET IMPACT ANALYSIS OF THE INCLUSION OF TOFACITINIB AS AN ALTERNATIVE FOR RHEUMATOID ARTHRITIS TREATMENT AFTER CONVENTIONAL DMARDS FAILURE IN CHILE

M.V. Gutierrez-Ardila

Value in Health | 2015

Economic Evaluation of Tofacitinib as Initial Medication In Adults With Rheumatoid Arthritis After Failure to Methotrexate In Chile

Z.M. Velasquez; L. Bustos Medina; A.C. De la Puente; S.C. Zaror; M.V. Gutierrez-Ardila

Value in Health | 2015

Costs Description of Rheumatoid Arthritis Treatment In Chile For Patients Who Have Failed To Conventional Synthetic Dmards

A.C. De la Puente; S.C. Zaror; Z.M. Velasquez; L. Bustos Medina; M.V. Gutierrez-Ardila

Value in Health | 2014

Impact On Health Status And Disease Specific Quality Of Life Of Tofacitinib In Patients With Inadequate Response To Non-Biological Disease-Modifying Antirheumatic Drugs (Dmard) Versus Anti-Tumor Necrosis Factor Drugs (Anti-Tnf) In Colombia

J.J. Vargas-Valencia; N. Vargas Zea; M.V. Gutierrez-Ardila

Value in Health | 2014

Functional Status And Labor Productivity With Tofacitinib In Patients With Inadequate Response To Non-Biological Disease-Modifying Antirheumatic Drugs (Dmard) Versus Anti-Tumor Necrosis Factor Drugs (Anti-Tnf) In Colombia

J.J. Vargas-Valencia; N. Vargas Zea; M.V. Gutierrez-Ardila

Explore More

Collaboration

Dive into the M.V. Gutierrez-Ardila's collaboration.

Top Co-Authors
Avatar

N. Vargas Zea

Pfizer

View shared research outputs
Top Co-Authors
Avatar

S.M. Nuñez

Pfizer

View shared research outputs
Top Co-Authors
Avatar

J.E. Ordoñez Molina

University of Antioquia

View shared research outputs
Top Co-Authors
Avatar

J.F. Mould-Quevedo

Pfizer

View shared research outputs
Top Co-Authors
Avatar

J.F. Mould

Pfizer

View shared research outputs
Top Co-Authors
Avatar

J.A. Cortes

National University of Colombia

View shared research outputs
Top Co-Authors
Avatar

A.C. De la Puente

University of La Frontera

View shared research outputs
Top Co-Authors
Avatar

L. Bustos Medina

University of La Frontera

View shared research outputs
Top Co-Authors
Avatar

S.C. Zaror

University of La Frontera

View shared research outputs
Top Co-Authors
Avatar

Z.M. Velasquez

University of La Frontera

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge